{
    "name": "erenumab",
    "comment": "Rx",
    "other_names": [
        "Aimovig"
    ],
    "classes": [
        "CGRP Monoclonal Antibodies",
        "Antimigraine Agents"
    ],
    "source": "https://reference.medscape.com/drug/aimovig-erenumab-1000205",
    "pregnancy": {
        "common": [
            "Data are not available regarding fetal risk if used in pregnant women"
        ],
        "specific": [
            {
                "type": "Animal studies",
                "description": [
                    "No adverse effects on offspring were observed when pregnant monkeys were administered erenumab-aooe throughout gestation"
                ]
            },
            {
                "type": "Clinical considerations",
                "description": [
                    "Data suggest that women with migraine may be at increased risk of preeclampsia and gestational hypertension during pregnancy"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Data are not available on the presence in human milk, the effects on the breastfed infant, or the effects on milk production",
            "Consider the developmental and health benefits of breastfeeding along with the motherâ€™s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to drug or excipients"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Hypersensitivity reactions (eg, rash, angioedema, anaphylaxis) reported; may occur within hours or one week following administration; discontinue administration and initiate appropriate therapy if serious reaction occurs"
            ],
            "specific": [
                {
                    "type": "Constipation",
                    "description": [
                        "Development of hypertension and worsening of pre-existing hypertension reported",
                        "Pre-existing hypertension or of risk factors increases risk",
                        "Pharmacological treatment may be necessary",
                        "May occur at anytime but most frequently within seven days of dose administration",
                        "Onset or worsening of hypertension usually reported after first dose",
                        "Monitor for new onset or worsening of pre-existing hypertension and consider whether discontinuation of therapy warranted if no alternate etiology found"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Injection site pain",
            "percent": "5-6"
        },
        {
            "name": "Constipation",
            "percent": "1-3"
        },
        {
            "name": "Cramps",
            "percent": "3"
        },
        {
            "name": "muscle spasms",
            "percent": null
        },
        {
            "name": "Immune system disorders",
            "percent": null
        },
        {
            "name": "Rash",
            "percent": null
        },
        {
            "name": "angioedema",
            "percent": null
        },
        {
            "name": "anaphylaxis",
            "percent": null
        },
        {
            "name": "hypersensitivity",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Oral mucosal ulceration",
            "percent": null
        },
        {
            "name": "constipation with serious complications",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        }
    ]
}